Investidor Profissional Gestao de Recursos Ltda. reduced its holdings in shares of Danaher Co. (NYSE:DHR – Free Report) by 81.8% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,013 shares of the conglomerate’s stock after selling 17,982 shares during the quarter. Danaher makes up approximately 0.4% of Investidor Profissional Gestao de Recursos Ltda.’s holdings, making the stock its 14th biggest position. Investidor Profissional Gestao de Recursos Ltda.’s holdings in Danaher were worth $1,003,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently made changes to their positions in DHR. Vanguard Group Inc. boosted its holdings in shares of Danaher by 7.4% in the 1st quarter. Vanguard Group Inc. now owns 60,107,030 shares of the conglomerate’s stock valued at $15,009,928,000 after buying an additional 4,163,657 shares during the last quarter. Wellington Management Group LLP lifted its stake in Danaher by 12.0% in the fourth quarter. Wellington Management Group LLP now owns 27,928,442 shares of the conglomerate’s stock valued at $6,460,966,000 after acquiring an additional 2,998,161 shares during the last quarter. Price T Rowe Associates Inc. MD grew its position in shares of Danaher by 10.7% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 16,757,558 shares of the conglomerate’s stock valued at $3,876,694,000 after acquiring an additional 1,619,586 shares during the period. Capital International Investors increased its stake in shares of Danaher by 9.1% during the 4th quarter. Capital International Investors now owns 15,956,519 shares of the conglomerate’s stock worth $3,691,735,000 after purchasing an additional 1,334,781 shares during the last quarter. Finally, Edgewood Management LLC raised its holdings in shares of Danaher by 7.7% in the 4th quarter. Edgewood Management LLC now owns 6,381,293 shares of the conglomerate’s stock valued at $1,476,248,000 after purchasing an additional 454,950 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling at Danaher
In other Danaher news, CEO Rainer Blair sold 9,007 shares of the firm’s stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $280.00, for a total value of $2,521,960.00. Following the sale, the chief executive officer now owns 97,983 shares of the company’s stock, valued at approximately $27,435,240. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In other news, CEO Rainer Blair sold 9,007 shares of the stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $280.00, for a total value of $2,521,960.00. Following the completion of the transaction, the chief executive officer now owns 97,983 shares of the company’s stock, valued at $27,435,240. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Georgeann Couchara sold 952 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $268.37, for a total transaction of $255,488.24. Following the completion of the sale, the senior vice president now owns 4,212 shares in the company, valued at $1,130,374.44. The disclosure for this sale can be found here. Insiders sold a total of 39,659 shares of company stock worth $11,042,433 over the last three months. Corporate insiders own 11.10% of the company’s stock.
Wall Street Analysts Forecast Growth
Read Our Latest Stock Report on DHR
Danaher Stock Performance
NYSE:DHR opened at $272.63 on Friday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.04 and a current ratio of 1.43. Danaher Co. has a fifty-two week low of $182.09 and a fifty-two week high of $281.70. The company has a market cap of $201.93 billion, a price-to-earnings ratio of 46.21, a PEG ratio of 4.48 and a beta of 0.83. The stock has a fifty day moving average price of $267.62 and a 200-day moving average price of $257.14.
Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings data on Tuesday, July 23rd. The conglomerate reported $1.72 earnings per share for the quarter, topping the consensus estimate of $1.57 by $0.15. Danaher had a net margin of 16.94% and a return on equity of 11.06%. The business had revenue of $5.74 billion during the quarter, compared to analysts’ expectations of $5.59 billion. During the same quarter in the prior year, the business posted $2.05 earnings per share. Danaher’s revenue was down 2.9% compared to the same quarter last year. As a group, equities analysts anticipate that Danaher Co. will post 7.59 EPS for the current fiscal year.
Danaher Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Friday, September 27th will be paid a $0.27 dividend. The ex-dividend date is Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.40%. Danaher’s dividend payout ratio (DPR) is 18.31%.
Danaher Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Recommended Stories
- Five stocks we like better than Danaher
- How to invest in marijuana stocks in 7 steps
- MarketBeat Week in Review – 9/16 – 9/20
- What is the Dow Jones Industrial Average (DJIA)?
- Don’t Miss These 3 Retail Stocks for Fall Gains
- Using the MarketBeat Dividend Yield Calculator
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.